RTTNews | Dec 6, 2021 06:33AM EST

06:33 Monday, December 6, 2021 (RTTNews) - Aeglea BioTherapeutics Phase 3 Study Of Pegzilarginase Meets Primary Endpoint In Patients With Arginase 1 Deficiency

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved